Table III.
Method | Scorpion-ARMS | Pyrosequencing | Luminex xMAP | ||||||
---|---|---|---|---|---|---|---|---|---|
Direct sequencing | W | M | NE | W | M | NE | W | M | NE |
W | 39 | 1 | 0 | 39 | 1 | 0 | 37 | 3 | 0 |
M | 0 | 28 | 0 | 0 | 28 | 0 | 0 | 28 | 0 |
NE | 3 | 0 | 2 | 2 | 0 | 3 | 1 | 0 | 4 |
κ=0.89672 | κ=0.92347 | κ=0.90004 | |||||||
Scorpion-ARMS | |||||||||
W | 41 | 0 | 1 | 37 | 2 | 3 | |||
M | 0 | 29 | 0 | 0 | 29 | 0 | |||
NE | 0 | 0 | 2 | 1 | 0 | 1 | |||
κ=0.97355 | κ=0.84502 | ||||||||
Pyrosequencing | |||||||||
W | 37 | 2 | 2 | ||||||
M | 0 | 29 | 0 | ||||||
NE | 1 | 0 | 2 | ||||||
κ=0.87238 |
KRAS, Kirsten rat sarcoma viral oncogene homolog; W, wild-type KRAS; M, mutated KRAS; NE, not evaluated.